Some SMBG time points had a stronger association with A1C than others.

Higher levels of A1c suggest worse blood sugar control and possibly diabetes.

Blood pressure and hemoglobin A1c did not differ among the four groups.

They were more likely to document patient height, urinalyses results, and A1C values.

High A1C levels mean a high risk of complications from diabetes.

BP and insulin resistance, reflected by hemoglobin A1c, were among cardiovascular risk factors.

Preprandial glucose values have a larger impact on A1C levels than postprandial values.

Meta-regression showed an association between higher baseline A1c and a larger effect size.

Conclusions: CHW interventions showed a modest reduction in A1c compared to usual care.

It compared levels of A1C -a measure of sugar in the bloodstream.

A1C is a commonly used measure of blood sugar over time.

Lipid profile, hemoglobin A1c and systemic blood pressure were measured in all patients.

Blood pressure, blood levels of hemoglobin A1c, and serum lipids were also measured.

These so-called hemoglobin A1c levels reflect average blood sugar levels over about three months.

A1C is a commonly used measure of a person's average blood glucose over time.

There was a graded association between A1C and carotid IMT.